Capillary.io is a recently created tool, which allows the diagnosis of autoimmune diseases such as scleroderma. This new medical software is based on artificial intelligence
Capillary.io is a new software that uses today’s deep learning techniques to improve the medical practice of nailfold capillaroscopy, a diagnosis process that consists of examining with a microscope the blood capillaries at the base of the nails of each finger of a patient.
By looking at capillaries, doctors can assess the health of the patient’s blood circulation, find abnormal capillaries, capillary loss, etc. which can lead to conditions such as scleroderma and dermatomyositis.
Recommended AI News: ConnectWise Launches Bug Bounty Program to Help Detect Security Vulnerabilities
Capillary.io is a new tool that improves capillaroscopy efficiency, objectiveness and boosts research by using AI to automatically detect, measure and classify capillaries by its shape and size, and also give useful and comprehensive metrics to doctors.
Recommended AI News: Kargo and AMP Project Partner To Bring Optimized Mobile Creative To AMP
This is the first tool, in internal medicine and rheumatology, to offer automation advantages to capillaroscopy, a well established technique that lacked proper tools. In the words of Dr. Patricia Fanlo, a user of Capillary.io and coordinator of GEAS-SEMI: “This tool allows us to speed up, improve and facilitate the performance and usefulness of capillaroscopy, systematizing and analyzing the clinical information obtained. We can obtain reports with clinical parameters quickly and easily that guide us in the diagnosis, for example, of diseases such as scleroderma, by studying the microcirculation of the capillaries near the base of the patient’s nail”.
Recommended AI News: Empire Technologies Risk Management Group Adds iCONECT to Its Cyber Toolkit to Meet Client Needs
Comments are closed, but trackbacks and pingbacks are open.